Conventionally, hospital blood banks are managing donor screening by sending the sample to the central laboratory for CBC analysis, requiring waiting time for the report to be used in decision-making. Additionally, quality control demands testing of the derived blood components, which is also done in the central laboratory. RBC-concentrates and PLT concentrates often require pre-dilution, which is not only cumbersome but also associated with a high probability of errors. For efficient donor screening, blood banks are in search for rapid and precise CBC analysis, preferably from a finger-stick blood like other rapid tests. A method for testing of the blood products derived from the donated blood that allow direct sampling without dilution would greatly benefit quality assurance.
Boule 3-part systems standard model fulfills these requirements, while providing blood banks precise and accurate analyzing capability, without the need of sending samples away for analysis.
Somnath Banerjee, Area Sales Director APAC, Boule Diagnostics
T P Smitesh, Customer Support Manager, LabX (distributor of Boule products in India)
Date| time | duration:
2021-09-09| 09:00 or 15:00 CET | 1 h
Who should attend:
Product management team and sales team staff of Boule appointed distributors.
Boule academy certification: Attendees of this application and technology training that pass the exam will obtain a certification.
Register: To register you have to go to our new platform Boule Academy.
If you have registered you will find the link to the webinar one day before the webinar is held on Boule Academy.
It will take 24 hours before your account is activated.
Register here: https://bouleacademy.talentlms.com/index
If you already have an account you don’t need to do anything right now, you will find the link to the webinar one day before the webinar is held on Boule Academy.
We look forward to meeting you online!